Drug of the Week: Sprycel Makes the High-Priced List
posted by Alicia Caramenico
on April 27, 2016
AHIP’s Center for Policy and Research examined 150 specialty drugs, and found that most patients’ prescription costs are more than $100,000 a year. One of the drugs studied was Sprycel, a leukemia treatment from Bristol-Myers Squibb that costs a typical patient $149,136 annually.
Patients who need this medication to treat their condition have witnessed the cost soar year after year. In 2007, 1 Sprycel pill cost $87.60, according to Bloomberg data. By 2014, the cost skyrocketed by 133 percent to $203 per pill.
Without greater transparency around drug pricing decisions, including yearly price hikes, the health care community is left struggling to find ways keep medications accessible and affordable to the patients who need them.